1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Calliditas Therapeutics AB (publ)
  6. News
  7. Summary
    CALTX   SE0010441584

CALLIDITAS THERAPEUTICS AB (PUBL)

(CALTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Monday Trading

12/20/2021 | 11:14am EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 4.44% 1.41 Delayed Quote.-62.40%
ARGENX SE -1.68% 293 Real-time Quote.-5.49%
ATAI LIFE SCIENCES N.V. 12.00% 3.64 Delayed Quote.-52.29%
AVADEL PHARMACEUTICALS PLC 7.19% 3.8 Delayed Quote.-52.97%
BIOFRONTERA AG 1.45% 1.05 Delayed Quote.-30.07%
BP PLC 0.07% 414.92 Delayed Quote.25.48%
CALLIDITAS THERAPEUTICS AB (PUBL) 2.08% 71.3 Delayed Quote.-38.08%
CARNIVAL CORPORATION 7.69% 14.28 Delayed Quote.-29.03%
EDAP TMS S.A. 3.84% 6.49 Delayed Quote.8.35%
FORWARD PHARMA A/S 8.25% 5.41 Delayed Quote.-9.38%
IDEX BIOMETRICS ASA 2.62% 1.173 Real-time Quote.-63.83%
IDEX CORPORATION 0.92% 186.17 Delayed Quote.-21.22%
LONDON BRENT OIL -1.02% 109.101 Delayed Quote.37.57%
MORPHOSYS AG -3.28% 17.855 Delayed Quote.-44.65%
PRUDENTIAL PLC 0.21% 961.6 Delayed Quote.-24.68%
VEON LTD. 4.10% 0.4669 Delayed Quote.-72.70%
VERONA PHARMA PLC 5.63% 3.75 Delayed Quote.-44.20%
VOXELJET AG 1.78% 4 Delayed Quote.-32.20%
WTI -0.16% 109.453 Delayed Quote.41.98%
All news about CALLIDITAS THERAPEUTICS AB (PUBL)
05/14Calliditas Therapeutics Launches an Online Patient Platform
AQ
05/14Calliditas Therapeutics AB Launches an Online Patient Platform
CI
05/10Calliditas Therapeutics to participate in upcoming investor conferences
AQ
05/02Number of shares and votes in Calliditas Therapeutics
AQ
04/29Number of shares and votes in Calliditas Therapeutics
AQ
04/28Calliditas Therapeutics 2021 Annual Report Published
AQ
04/27CALLIDITAS THERAPEUTICS : rsquo; 2021 Annual Report Published
PU
04/27Calliditas Therapeutics' 2021 Annual Report Published
AQ
04/14CALLIDITAS THERAPEUTICS : Notice of annual general meeting of Calliditas Therapeutics AB (..
PU
04/14Notice of annual general meeting of Calliditas Therapeutics AB (publ)
AQ
More news
Analyst Recommendations on CALLIDITAS THERAPEUTICS AB (PUBL)
More recommendations
Financials
Sales 2022 532 M 53,0 M 53,0 M
Net income 2022 -601 M -59,8 M -59,8 M
Net cash 2022 6,81 M 0,68 M 0,68 M
P/E ratio 2022 -6,53x
Yield 2022 -
Capitalization 3 714 M 369 M 369 M
EV / Sales 2022 6,96x
EV / Sales 2023 1,90x
Nbr of Employees 86
Free-Float 82,0%
Chart CALLIDITAS THERAPEUTICS AB (PUBL)
Duration : Period :
Calliditas Therapeutics AB (publ) Technical Analysis Chart | CALTX | SE0010441584 | MarketScreener
Technical analysis trends CALLIDITAS THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 69,85 SEK
Average target price 202,50 SEK
Spread / Average Target 190%
EPS Revisions
Managers and Directors
Renée Julie Elisabet Aguiar-Lucander Chief Executive Officer
Fredrik Johansson Chief Financial Officer
Elmar J. Schnee Chairman
Johan Erik Häggblad Chief Scientific Officer
Richard Philipson Chief Medical Officer
Sector and Competitors